← Open Payments lookup

AMANDA RUTHERFORD: Open Payments

NPI 1518100908 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,869 in 142 payments from 23 companies in 2025. Trend: 2023 $800 · 2024 $2,842 · 2025 $2,869

Food & beverage: $2,869
CompanyPaymentsAmount
UCB, Inc.19$539
Novartis Pharmaceuticals Corporation14$253
ABBVIE INC.16$235
EMD Serono, Inc.8$211
Neurelis, Inc.5$202
SK Life Science, Inc.7$183
Genentech USA, Inc.9$178
ARGENX US, INC.7$155
Neurocrine BioSciences, Inc.19$147
Biogen, Inc.6$137

Products named: KESIMPTA, Briviact, VALTOCO, Nayzilam, Ocrevus Zunovo, QULIPTA, VYVGART HYTRULO, INGREZZA.

Industry payments across LA — which companies pay providers there.